Patents and the poor
The provision of medicines in poor countries has become the principle focus of dispute in the wider debate on intellectual property rights and whether they should be included in World Trade
Related Content
- Open source drug discovery in practice: A case study
- A win-win solution?: A critical analysis of tiered pricing to improve access to medicines in developing countries
- Views differ on WTOs generics solution, IPR enforcement
- Misguided research
- Differentiated intellectual property regimes for environmental and climate technologies
- Access to medicines back on centre stage at the WTO